Delta-Fly Pharma, Inc. (4598.T)

JPY 435.0

(1.16%)

Gross Profit Summary of Delta-Fly Pharma, Inc.

  • Delta-Fly Pharma, Inc.'s latest annual gross profit in 2023 was -1.51 Million JPY , up 7.35% from previous year.
  • Delta-Fly Pharma, Inc.'s latest quarterly gross profit in 2024 Q1 was -394 Thousand JPY , up 16.83% from previous quarter.
  • Delta-Fly Pharma, Inc. reported a annual gross profit of -1.63 Million JPY in annual gross profit 2022, down -100.54% from previous year.
  • Delta-Fly Pharma, Inc. reported a annual gross profit of 300 Million JPY in annual gross profit 2021, down 0.0% from previous year.
  • Delta-Fly Pharma, Inc. reported a quarterly gross profit of -1.51 Million JPY for 2023 FY, up 7.35% from previous quarter.
  • Delta-Fly Pharma, Inc. reported a quarterly gross profit of -331 Thousand JPY for 2023 Q1, up 16.83% from previous quarter.

Annual Gross Profit Chart of Delta-Fly Pharma, Inc. (2023 - 2019)

Historical Annual Gross Profit of Delta-Fly Pharma, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 -1.51 Million JPY 7.35%
2022 -1.63 Million JPY -100.54%
2021 300 Million JPY 0.0%
2020 300 Million JPY 200.0%
2019 100 Million JPY 0.0%

Peer Gross Profit Comparison of Delta-Fly Pharma, Inc.

Name Gross Profit Gross Profit Difference
KOHJIN BIO CO LTD 1.88 Billion JPY 100.08%
PRISM BioLab Co.,LTD 80.3 Million JPY 101.883%
GNI Group Ltd. 22.43 Billion JPY 100.007%
Linical Co., Ltd. 3.77 Billion JPY 100.04%
Trans Genic Inc. 2.24 Billion JPY 100.067%
MEDINET Co., Ltd. 98.25 Million JPY 101.539%
Soiken Holdings Inc. 2.48 Billion JPY 100.061%
Cytori Cell Research Institute, Inc. 1.29 Billion JPY 100.117%
AnGes, Inc. -3.06 Billion JPY 99.951%
OncoTherapy Science, Inc. -177.71 Million JPY 99.149%
Nxera Pharma Co., Ltd. 9.66 Billion JPY 100.016%
Immuno-Biological Laboratories Co., Ltd. 517.29 Million JPY 100.292%
NanoCarrier Co., Ltd. 110.95 Million JPY 101.363%
Carna Biosciences, Inc. 1.45 Billion JPY 100.104%
CanBas Co., Ltd. -984 Million JPY 99.846%
D. Western Therapeutics Institute, Inc. 391.69 Million JPY 100.386%
RaQualia Pharma Inc. 1.65 Billion JPY 100.091%
Chiome Bioscience Inc. 398.59 Million JPY 100.379%
Kidswell Bio Corporation 1.03 Billion JPY 100.145%
PeptiDream Inc. 17.21 Billion JPY 100.009%
Oncolys BioPharma Inc. 30.6 Million JPY 104.94%
Ribomic Inc. -10.5 Million JPY 85.603%
SanBio Company Limited -14.5 Million JPY 89.575%
Healios K.K. 108 Million JPY 101.4%
BrightPath Biotherapeutics Co., Ltd. -341 Thousand JPY -343.402%
Kubota Pharmaceutical Holdings Co., Ltd. -59.04 Million JPY 97.439%
StemRIM -44.34 Million JPY 96.591%
CellSource Co., Ltd. 3.18 Billion JPY 100.047%
FunPep Company Limited -680.28 Million JPY 99.778%
Kringle Pharma, Inc. 69.25 Million JPY 102.183%
Stella Pharma Corporation 217.29 Million JPY 100.696%
TMS Co., Ltd. -6.95 Million JPY 78.245%
Noile-Immune Biotech Inc. 314.56 Million JPY 100.481%
Cuorips Inc. 9.63 Million JPY 115.699%
K Pharma,Inc. 910 Million JPY 100.166%
Takara Bio Inc. 25.45 Billion JPY 100.006%
ReproCELL Incorporated 1.1 Billion JPY 100.137%
PhoenixBio Co., Ltd. 1.19 Billion JPY 100.127%
StemCell Institute Inc. 1.57 Billion JPY 100.096%
Japan Tissue Engineering Co., Ltd. 1.66 Billion JPY 100.091%
CellSeed Inc. 107.15 Million JPY 101.411%